Lv3
220 积分 2024-07-15 加入
FDA approves first HER2 × HER3 bispecific antibody
2天前
已完结
2O ERBB3 mRNA expression in breast cancer (BC): A SOLTI biomarker discovery analysis
3天前
求助中
Abstract P1-04-05: Multiplexed immunofluorescence staining of intra-tumoral immune cell populations and associations with immunohistochemical, clinical, and pathologic variables in breast cancer
14天前
已关闭
Prognostic and predictive value of phosphorylated HER2, HER3 and PTEN expression in patients with HER2-positive breast cancer treated with trastuzumab
14天前
已关闭
Emerging importance of HER3 in tumorigenesis and cancer therapy
15天前
已完结
Immunohistochemical expression of HER1, HER3, and HER4 in HER2‐positive breast cancer patients treated with trastuzumab‐containing neoadjuvant chemotherapy
16天前
已完结
Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy
17天前
已完结
Comparison of Antibodies for Immunohistochemistry-based Detection of HER3 in Breast Cancer
21天前
已完结
103P Loss of HER2 after neoadjuvant treatment of HER2+ early breast cancer
1个月前
已关闭
High‐grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex
1个月前
已完结
皖公网安备34019202002308
